article · Antibiotics

Determining the Use and Reasons for Non-De-Escalation of Empiric Carbapenem Therapy in a Private Hospital in South Africa

2025Open accessSefako Makgatho Health Sciences University

In plain language

The abstract on record is too brief for a reliable plain-language summary, so none has been generated.

Abstract

The study came to the conclusion that prescribers do not want to de-escalate once their patients are improving on current treatment or if there are no cultures available.

Research topics

Antibiotic Use and Resistance
Antibiotic Resistance in Bacteria
Antibiotics Pharmacokinetics and Efficacy

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.3390/antibiotics14121220

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.